未知原发癌的宫颈淋巴结病的处理。

IF 1.4 4区医学 Q4 ONCOLOGY

Cancer Radiotherapie Pub Date : 2025-09-16 DOI:10.1016/j.canrad.2025.104721

Xavier Musset , Idriss Troussier , Nolwenn Delaby , Pierre Blanchard , Yoann Pointreau , Sébastien Thureau

{"title":"未知原发癌的宫颈淋巴结病的处理。","authors":"Xavier Musset , Idriss Troussier , Nolwenn Delaby , Pierre Blanchard , Yoann Pointreau , Sébastien Thureau","doi":"10.1016/j.canrad.2025.104721","DOIUrl":null,"url":null,"abstract":"<div><div>Cervical lymphadenopathy of unknown primary tumour is a rare entity. In this situation, exhaustive diagnostic procedures are essential, including a comprehensive clinical examination, complete imaging, multiples biopsies and molecular testing. Localized disease cT0N1/N2a or low volumes N2b negative for Epstein-Barr virus can be treated either by surgery alone or unilateral neck radiation. For tumours N2b or above, either bilateral radiotherapy is proposed or chemoradiotherapy with cisplatin. Intensity-modulated radiotherapy is the standard technique of irradiation for the management of cervical lymphadenopathies of unknown primary origin. Dose regimens for postoperative or exclusive radiotherapy are detailed in this article, as well as the selection of prophylactic tumour and lymph node target volumes.</div></div>","PeriodicalId":9504,"journal":{"name":"Cancer Radiotherapie","volume":"29 7","pages":"Article 104721"},"PeriodicalIF":1.4000,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Management of cervical lymphadenopathies of unknown primary cancer\",\"authors\":\"Xavier Musset , Idriss Troussier , Nolwenn Delaby , Pierre Blanchard , Yoann Pointreau , Sébastien Thureau\",\"doi\":\"10.1016/j.canrad.2025.104721\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Cervical lymphadenopathy of unknown primary tumour is a rare entity. In this situation, exhaustive diagnostic procedures are essential, including a comprehensive clinical examination, complete imaging, multiples biopsies and molecular testing. Localized disease cT0N1/N2a or low volumes N2b negative for Epstein-Barr virus can be treated either by surgery alone or unilateral neck radiation. For tumours N2b or above, either bilateral radiotherapy is proposed or chemoradiotherapy with cisplatin. Intensity-modulated radiotherapy is the standard technique of irradiation for the management of cervical lymphadenopathies of unknown primary origin. Dose regimens for postoperative or exclusive radiotherapy are detailed in this article, as well as the selection of prophylactic tumour and lymph node target volumes.</div></div>\",\"PeriodicalId\":9504,\"journal\":{\"name\":\"Cancer Radiotherapie\",\"volume\":\"29 7\",\"pages\":\"Article 104721\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2025-09-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Radiotherapie\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1278321825001374\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Radiotherapie","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1278321825001374","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

摘要

摘要未知原发肿瘤的宫颈淋巴结病是一种罕见的肿瘤。在这种情况下，详尽的诊断程序是必不可少的，包括全面的临床检查、完整的成像、多次活检和分子检测。局部疾病cT0N1/N2a或低体积N2b eb病毒阴性可通过单独手术或单侧颈部放射治疗。对于N2b或以上的肿瘤，建议采用双侧放疗或顺铂放化疗。调强放疗是治疗原发原因不明的颈部淋巴结病的标准放疗技术。本文详细介绍了术后或单独放疗的剂量方案，以及预防性肿瘤和淋巴结靶体积的选择。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Management of cervical lymphadenopathies of unknown primary cancer

Cervical lymphadenopathy of unknown primary tumour is a rare entity. In this situation, exhaustive diagnostic procedures are essential, including a comprehensive clinical examination, complete imaging, multiples biopsies and molecular testing. Localized disease cT0N1/N2a or low volumes N2b negative for Epstein-Barr virus can be treated either by surgery alone or unilateral neck radiation. For tumours N2b or above, either bilateral radiotherapy is proposed or chemoradiotherapy with cisplatin. Intensity-modulated radiotherapy is the standard technique of irradiation for the management of cervical lymphadenopathies of unknown primary origin. Dose regimens for postoperative or exclusive radiotherapy are detailed in this article, as well as the selection of prophylactic tumour and lymph node target volumes.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Cancer Radiotherapie 医学-核医学

CiteScore

2.20

自引率

23.10%

发文量

129

审稿时长

63 days

期刊介绍： Cancer/radiothérapie se veut d''abord et avant tout un organe francophone de publication des travaux de recherche en radiothérapie. La revue a pour objectif de diffuser les informations majeures sur les travaux de recherche en cancérologie et tout ce qui touche de près ou de loin au traitement du cancer par les radiations : technologie, radiophysique, radiobiologie et radiothérapie clinique.